Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus-positive subjects: A cross-sectional study

Clinical Infectious Diseases

Volumn 36, Issue 12, 2003, Pages 1593-1601

  Gavrila, Alina ^a   Tsiodras, Sotirios ^a   Doweiko, John ^a   Nagy, G Sonia ^a   Brodovicz, Kimberly ^c   Hsu, William ^b   Karchmer, Adolf W ^a   Mantzoros, Christos S ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL; ANTIOXIDANT;

ADULT; ARTICLE; BODY FAT; DIASTOLIC BLOOD PRESSURE; DIET; DIETARY INTAKE; DYSLIPIDEMIA; EXERCISE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIVARIATE ANALYSIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; BLOOD PRESSURE; BODY COMPOSITION; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; EATING; HIV ASSOCIATED LIPODYSTROPHY; HYPERLIPIDEMIA; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIOXIDANTS; BLOOD PRESSURE; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; DIET; DIETARY SUPPLEMENTS; EATING; EXERCISE; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MALE; MIDDLE AGED; VITAMIN E;

EID: 0038548197     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/375225     Document Type: Article

References (59)

1. Shevitz A, Wanke CA, Falutz J, Kotler DP. Clinical perspectives on HIV-associated lipodystrophy syndrome: an update. AIDS 2001; 15:1917-30.
2. Tsiodras S, Mantzoros C, Hammer S, Samore M. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med 2000; 160:2050-6.
3. Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use. J Clin Endocrinol Metab 2000; 85:35-41.
4. Hadigan C, Miller K, Corcoran C, Anderson E, Basgoz N, Grinspoon S. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 1999; 84:1932-7.
5. Grunfeld C, Pang M, Doerrler W, Shigenaga J, Jensen P, Feingold K. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992; 74:1045-52.
6. Nolan D, Mallal S. Getting to the HAART of insulin resistance. AIDS 2001; 15:2037-41.
7. Mulligan K, Grunfeld C, Tai VW, et al. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr 2000; 23:35-43.
8. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32:130-9.
9. Depairon M, Chessex S, Sudre P, et al. Premature atherosclerosis in HIV-infected individuals - focus on protease inhibitor therapy. AIDS 2001; 15:329-34.
10. Lewis W. Atherosclerosis in AIDS: potential pathogenic roles in anti-retroviral therapy and HIV. J Mol Cell Cardiol 2000; 32:2115-29.
11. Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998; 351:1328.
12. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337:725-33.
13. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-60.
14. Howell WH, McNamara DJ, Tosca MA, Smith BT, Gaines JA. Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis. Am J Clin Nutr 1997; 65:1747-64.
15. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb 1992; 12:911-9.
16. Kromhout D. Diet and cardiovascular diseases. J Nutr Health Aging 2001; 5:144-9.
17. Berry EM. Dietary fatty acids in the management of diabetes mellitus. Am J Clin Nutr 1997;66(Suppl 4):S991-7.
18. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy S, Brinkley L. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342:1392-8.
19. Rice B, Hudson R, Janssen I, Ross R. Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men. Diabetes Care 1999; 22:684-91.
20. Ross R, Dagnone D, Jones PJH, et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. Ann Intern Med 2000; 133:92-103.
21. Boulé NG, Haddad E, Kenny GP, Wells G, Sigal R. Effects of exercise of glycemic control and body mass in type 2 diabetes mellitus. JAMA 2001; 286:1218-27.
22. Katzel LI, Bleecker ER, Colman EG, Rogus EM, Sorkin JD, Goldberg AP. Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. JAMA 1995; 274:1915-21.
23. Yarasheski KE, Tebas P, Stanerson B, et al. Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with anti-viral therapy. J Appl Physiol 2001; 90:133-8.
24. Jones SP, Doran DA, Leatt PB, Maher B, Pirmohamed M. Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy. AIDS 2001; 15:2049-51.
25. Roubenoff R, Weiss L, McDermott A, et al. A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 1999; 13:1373-5.
26. Smith BA, Neidig JL, Nickel JT, Mitchell G, Para M, Fass R. Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS 2001; 15:693-701.
27. Batterham MJ, Garsia R, Greenop PA. Dietary intake, serum lipids, insulin resistance and body composition in the era of highly active antiretroviral therapy. Diet FRS Study. AIDS 2000; 14:1839-43.
28. Hadigan C, Jeste S, Anderson EJ, Tsay R, Cyr H, Grinspoon S. Modifiable dietary habits and their relation to metabolic abnormalities in men and women with human immunodeficiency virus infection and fat redistribution. Clin Infect Dis 2001; 33:710-7.
29. Wilson TA, McIntyre M, Nicolosi RJ. Trans fatty acids and cardiovascular risk. J Nutr Health Aging 2001; 5:184-7.
30. Prince MJ, Deeg MA. Do n-3 fatty acids improve glucose tolerance and lipemia in diabetics? Curr Opin Lipidol 1997; 8:7-11.
31. Campbell LV, Marmot PE, Dyer JA, Borkman M, Storlien LH. The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 1994; 17:177-82.
32. Barbagallo M, Dominquez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of vitamin E and glutathione on glucose metabolism: role of magnesium. Hypertension 1999; 34:1002-6.
33. Roubenoff R, Schmitz H, Bairos L, et al. Reduction of abdominal obesity in lipodystrophy associated with human immunodeficiency virus infection by means of diet and exercise: case report and proof of principle. Clin Infect Dis 2002; 34:390-3.
34. Addy CL, Gavrila A, Tsiodras S, Brodovicz K, Karchmer AW, Mantzoros CS. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in HIV-infected patients treated with HAART. J Clin Endocrinol Metab 2003; 88:627-36.
35. Block G, Hartman AM, Dresser CM, Carrol MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986; 124:453-69.
36. Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990; 43:1327-35.
37. Mares-Perlman JA, Klein BE, Klein R, Ritter LL, Fisher MR, Freudenheim JL. A diet history questionnaire ranks nutrient intakes in middle-aged and older men and women similarly to multiple food records. J Nutr 1993; 123:489-501.
38. Block G, Coyle LM, Hartman AM, Scoppa SM. Revision of dietary analysis software for the health habits and history questionnaire. Am J Epidemiol 1994; 139:1190-6.
39. Mantzoros CS, Georgiadis EI. Body mass and physical activity are important predictors of serum androgen concentrations in young healthy men. Epidemiology 1995; 6:432-5.
40. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta 1987; 166:1-8.
41. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-magnesium precipitation procedure for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982; 28:1379-82.
42. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
43. Howard G, Bergman R, Wagenknecht LE, et al. Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the "minimal model." Ann Epidemiol 1998; 8:358:69.
44. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000; 85:4426-33.
45. Clasey JL, Hatman MI, Kanaley J, et al. Body composition by DEXA in older adults: accuracy and influence of scan mode. Med Sci Sports Exerc 1997; 29:560-7.
46. Economos CD, Nelson ME, Fiatarone MA, et al. A multi-center comparison of dual energy x-ray absorptiometers: in vivo and in vitro soft tissue measurement. Eur J Clin Nutr 1997; 51:312-7.
47. Jensen MD, Kanaley JA, Reed JE, Sheedy PF. Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 1995; 61:274-8.
48. Weits T, Van der Beek EJ, Wedel M, Ter Harr Romeny BM. Computed tomography measurement of abdominal fat deposition in relation to anthropometry. Int J Obes 1988; 12:217-25.
49. Thaete F, Colberg S, Burke T, Kelley DE. Reproducibility of computed tomography measurement of visceral adipose tissue area. Int J Obes Relat Metab Disord 1995; 19:464-7.
50. Busetto L, Baggio M, Zurlo F, Digito M, Enzi G. Assessment of abdominal fat distribution in obese patients: anthropometry versus computerized tomography. Int J Obes Relat Metab Disord 1992; 16:731-6.
51. Lauber RP, Sheard NF, American Heart Association. The American Heart Association dietary guidelines for 2000: a summary report. Nutr Rev 2001; 59:298-306.
52. Martin WH III. Effects of acute and chronic exercise on fat metabolism. Exerc Sport Sci Rev 1996; 24:203-31.
53. Seip RL, Semenkovich CF. Skeletal muscle lipoprotein lipase: molecular regulation and physiological effects in relation to exercise. Exerc Sport Sci Rev 1998; 26:191-218.
54. Hardman AE. The influence of exercise on postprandial triacylglycerol metabolism. Atherosclerosis 1998; 141(Suppl 1):S93-100.
55. Paolisso G, Tagliamonte MR, Barbieri M, et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. J Clin Endocrinol Metab 2000; 85:109-15.
56. Ceriello A, Giugliano D, Quatraro A, Lefebvre PJ. Anti-oxidants show an anti-hypertensive effect in diabetics and hypertensive subjects. Clin Sci 1991; 81:739-42.
57. Costagliola C, Menzione M. Effect of vitamin E on the oxidative state of glutathione in the plasma. Clin Physiol Biochem 1990; 8:140-3.
58. Rayssiguier Y, Durlach J, Gueux E, Rock, Mazur A. Magnesium and ageing. Experimental data: importance of oxidative damage. Magnes Res 1993; 6:369-78.
59. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997; 10:346-55.